Login Email
Password
CancerNetwork Members:
Login
|
Register
Enter Search Term Here
SearchMedica recommended medical sites
Search CancerNetwork
Search PubMed's Medline
Cancer Network
Publications
News
Conference Reports
Podcasts
CME
E-Learning
Classifieds
Supplements
Practice Management
For Patients
TOPIC CENTERS
Breast Cancer
Colorectal Cancer
Gynecologic Cancers
Head & Neck Cancer
Integrative Oncology
Kidney Cancer
Leukemia and Lymphoma
Lung Cancer
Melanoma and Other Skin Cancers
Multiple Myeloma
Nausea & Vomiting
Palliative and Supportive Care
Pancreatic Cancer
Prostate Cancer
Renal Cell Carcinoma
Survivorship
Triple-Negative Breast Cancer
Testicular Cancer
More Topics
MORE INFO
Cancer Management
E-Textbooks
Oncology NEWS Today Blog
Contact Us
Newsletter Signup
Media Kit
Subscribe to RSS
Home
»
Publications
»
Oncology NEWS International
»
Oncology News Table of Contents
Oncology NEWS International Vol 16 No 11
Cover Story
Name:
Description:
Sides dig in as ESA policy debate heats up
Accelerated approval for Tasigna
Focus on Breast Cancer
Name:
Description:
Experts disagree on taxane use in HER2-/ ER+ breast ca
Prophylactic contralateral mastectomies are on the rise
News & Analysis
Name:
Description:
Dr. Norton hopes to weed 'molecular' tumor garden
Focus on Hematology
Name:
Description:
R-CHOP is standard of care for advanced DLBCL patients
Focus on Colon Cancer
Name:
Description:
Virtual colonoscopy: Is the validation phase finally over?
MT103, BiTE antibody, enters phase II testing for ALL
Ixempra gets ok for resistant breast cancer
ASCO adds Onco
type
DX to marker guideline
Oxidative stress inducer ups survival in advanced melanoma
FDA removes partial hold on Telcyta clinical development
Should all HER2+ pts receive adjuvant trastuzumab?
Diagnostic Dilemma: GI Disease
FDA oks Velcade for patients with renal dysfunction
Phase II trials planned for oral methylnaltrexone for chronic pain
GSK and Synta announce STA-4783 collaboration
2007: A tumultuous year for erythropoietic-stimulating agents
MB07133 gets orphan drug status
Research funds pay off with mortality decline
IL-21/sorafenib promising in renal cancer
Satraplatin pivotal phase III trial fails to meet primary endpoint
Oral Hycamtin gets FDA approval for relapsed SCLC
A prescription for fixing what ails Medicare
Interim analysis is underway of BiovaxID trial in NHL
13% of patients stop aromatase inhibitors due to joint, muscle pain
Preop MRI for breast cancer: Intuition no substitute for data
CT lung ca screening: Is the controversy overblown?
FDA's drug approval process is caught in crossfire
Ganz, Joranson receive ACS Distinguished Service Award
Sunitinib lowers PSA in some advanced prostate cancer pts
Ablative therapy of primary breast ca in phase II trial
Lab-on-a-chip sensor rapidly diagnoses oral cancer
